# FDA 483 - Misemer Pharmaceutical - February 23, 2026

Source: https://www.keypedia.com/records/483/misemer-pharmaceutical/fd010587-cd1b-4ca0-bf4c-570ecc1165e5

> FDA 483 for Misemer Pharmaceutical on February 23, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Misemer Pharmaceutical
- Inspection Date: 2026-02-23
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: Misemer Pharmaceutical, Inc. in Ripley, MS, was inspected regarding its role as an Own Label Distributor. The inspection revealed significant deficiencies in the timely submission of quarterly and annual adverse drug experience reports and annual reports for multiple drug products. Additionally, the firm lacked adequate written procedures for reporting postmarketing adverse drug experiences to the FDA.

## Related Documents

- [483 - 2026-02-23](https://www.keypedia.com/records/483/misemer-pharmaceutical/ee8f2b1b-e017-472d-a95c-f6f5f81199fd)

## Related Officers

- [investigator](https://www.keypedia.com/people/kellie-r-riggs/556818c6-eb9a-48a5-9630-aba7a807ec07)

Company: https://www.keypedia.com/companies/misemer-pharmaceutical/8519598e-b9c3-4cfa-a622-37863a4f50fe

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea